SCHEMBL27713177

SCHEMBL27713177

CC(C)(NC(=O)c1cc(F)c2ccccc2c1Cc1ccc(OC(F)(F)F)cc1)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 4/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ CHRM1 P11229 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ NR1H4 Q96RI1 1/20 0.41
▸ CTNNB1 P35222 1/20 0.39
▸ TCF7L2 Q9NQB0 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ PPARA Q07869 2/20 0.39
▸ PTPRC P08575 1/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ PTPN1 P18031 1/20 0.39
▸ PTPN6 P29350 1/20 0.39
▸ PTPN9 P43378 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ PTPN22 Q9Y2R2 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485338 0.85 CXCR2 (0.49) CXCR2KDM4EEPHX2NR1H4PPARD
SCHEMBL27693225 0.79 KDM4E (0.44) CXCR2KDM4EEPHX2NR1H4CTNNB1
SCHEMBL485436 0.75 KDM4E (0.54) CXCR2KDM4EEPHX2NR1H4TRPV1
SCHEMBL485243 0.75 CXCR2 (0.45) CXCR2KDM4EEPHX2NR1H4PPARD
SCHEMBL485456 0.74 CXCR2 (0.49) CXCR2KDM4E
SCHEMBL484851 0.74 CXCR2 (0.60) CXCR2KDM4EEPHX2NR1H4PPARA
SCHEMBL485751 0.74 KDM4E (0.71) CXCR2KDM4E
SCHEMBL485484 0.73 CXCR2 (0.49) CXCR2KDM4E
SCHEMBL485080 0.73 CXCR2 (0.56) CXCR2KDM4EPPARDPPARAPTPN1
SCHEMBL3925217 0.72 CXCR2 (0.62) CXCR2KDM4EPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 — — CN claimed
Send feedback